DNA methylation regulates TIGIT expression within the melanoma microenvironment, is prognostic for overall survival, and predicts progression-free survival in patients treated with anti-PD-1 immunotherapy

BACKGROUND: TIGIT is an immune checkpoint under investigation as therapeutic target. Understanding the regulation of TIGIT on an epigenetic level might support the development of companion biomarkers. METHODS: We correlated TIGIT DNA methylation of single CpG sites with gene expression, signatures o...

Descripción completa

Detalles Bibliográficos
Autores principales: Niebel, Dennis, Fröhlich, Anne, Zarbl, Romina, Fietz, Simon, de Vos, Luka, Vogt, Timo J., Dietrich, Jörn, Sirokay, Judith, Kuster, Pia, Saavedra, Gonzalo, Ramírez Valladolid, Susana, Hoffmann, Friederike, Strieth, Sebastian, Landsberg, Jennifer, Dietrich, Dimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004005/
https://www.ncbi.nlm.nih.gov/pubmed/35410311
http://dx.doi.org/10.1186/s13148-022-01270-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004005/
https://www.ncbi.nlm.nih.gov/pubmed/35410311
http://dx.doi.org/10.1186/s13148-022-01270-2

Ejemplares similares